IGF::OT::IGF TITLE: CHEMO-ENZYMATIC SYNTHESIS OF STRUCTURALLY DEFINED COMPLEX-TYPE N-GLYCANS
IGF::OT::IGF TITLE: CHEMO-ENZYMATIC SYNTHESIS OF STRUCTURALLY DEFINED COMPLEX-TYPE N-GLYCANS
批准号:
9154682
负责人:
LIU YUNPENG, PH.D.
金额:
$99.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-18 至 2017-09-17
关键词:
ChemicalsComplexContractorDevelopmentDiagnosticDiseaseEnzymesGlycobiologyGlycoside HydrolasesHigh Pressure Liquid ChromatographyLibrariesMalignant NeoplasmsMethodologyMethodsNatural ResourcesPhasePolysaccharidesProcessResearchStructureTherapeuticVendorbasecarbohydrate binding proteinchemical synthesisglycosyltransferaseimproved
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Access to structurally defined N-glycans is an urgent scientific need for glycan arrays for rapid analysis of carbohydrate binding proteins (CBPs), development of diagnostics and therapeutics for many diseases, as well as glycoanalysis. However, only a small number of N-glycans are currently commercially available, most of which are symmetric ones. The lack of structurally defined glycans has greatly hampered research in Glycobiology. Due to complexity and low abundance of N-glycans, it is extremely difficult to separate and purify homogenous N-glycans from natural resources. Thus chemical synthesis of N-glycans has been pursued instead. However, very limited N-glycans have been synthesized due to challenges in the chemical methodology. In the preceding Phase I proposal, the contractor developed a facile and efficient chemical core synthesis with an enzymatic extension (CCSEE) strategy and a rapid HPLC-based purification approach for N-glycan synthesis. The contractor successfully prepared 75 structurally defined N-glycans with a purity of 98%. In this Phase II project, the Contractor shall further improve the CCSEE strategy for synthesis of cancer-related N-glycans, including Neu5Gc-terminated, core-fucosylated, bisected, and 1,6 branched N-glycans. These glycans cover the chemical space of bi-, tri- and tetra-antennary complex-type N-glycans. This process involves several well-characterized glycosyltransferases, glycoside hydrolases, and other enzymes. All the proposed N-glycans shall be purified to 98%, and fully characterized by HPLC, MS, and partially by NMR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
-
批准号:32370337
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:王杰
-
依托单位:
二甲双胍对于模型蛋白、γ-secretase、Complex I自由能曲面的影响
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭子龙
-
依托单位:
高脂饮食损伤巨噬细胞ndufs4表达激活Complex I/mROS/HIF-1通路参与溃疡性结肠炎研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵锐
-
依托单位:
线粒体参与呼吸中枢pre-Bötzinger complex呼吸可塑性调控的机制研究
-
批准号:31971055
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘莹莹
-
依托单位:
北温带中华蹄盖蕨复合体Athyrium sinense complex的物种分化
-
批准号:31872651
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:张宪春
-
依托单位:
边缘鳞盖蕨复合体种 (Microlepia marginata complex) 的网状进化及物种形成研究
-
批准号:31860044
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2018
-
负责人:王任翔
-
依托单位:
益气通络颗粒及主要单体通过调节cAMP/PKA/Complex I通路治疗气虚血瘀证脑梗死的机制研究
-
批准号:81703747
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:薛冰洁
-
依托单位:
生物钟转录抑制复合体 Evening Complex 调控茉莉酸诱导叶片衰老的分子机制研究
-
批准号:31670290
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:张媛媛
-
依托单位:
延伸子复合物(Elongator complex)的翻译调控作用
-
批准号:31360023
-
项目类别:地区科学基金项目
-
资助金额:51.0万元
-
批准年份:2013
-
负责人:黄波
-
依托单位:
Complex I 基因变异与寿命的关联及其作用机制的研究
-
批准号:81370445
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:杨泽
-
依托单位: